Jason A. Lief, Partner, Windels Marx Lane & Mittendorf, LLP to Speak at The Knowledge Group’s Latest Hatch-Waxman Developments
The Knowledge Group, the leading producer of regulatory-focused webcasts, has announced today that Jason A. Lief, Partner, Windels Marx Lane & Mittendorf, LLP will speak at its webcast entitled, “Orange Book Listings and Obviousness: Latest Hatch-Waxman Developments.”
- (1888PressRelease) May 17, 2025 - This event is scheduled for May 29, 2025, from 12:00 PM to 1:00 PM (ET).
For further details, please visit:
https://knowlearninghub.com/courses/orange-book-hatch-wax-cle/
About Jason A. Lief
Jason Lief is a premier patent trial lawyer with 28 years of experience. He has litigated and tried dozens of major patent, Hatch-Waxman, and other intellectual property cases on behalf of some of the world’s most innovative and dynamic companies, often involving billion dollar products. Applying his legal and scientific training, Jason has established a reputation for winning outcomes and courtroom excellence.
About Windels Marx Lane & Mittendorf, LLP
WINDELS MARX LANE & MITTENDORF, LLP, is a full service law firm formed by the merger of two high quality, well known firms, Windels, Marx, Davies & Ives, with roots dating from the 1830's, and Lane & Mittendorf, LLP, itself one half century old. We represent a diverse group of domestic and international clients in a broad-based general legal practice centering on corporate, bankruptcy, litigation, real estate, banking, and other major business practice areas.
Event Summary
Explore the latest developments in Hatch-Waxman litigation, with a deep dive into the legal and regulatory complexities surrounding Orange Book listings and the evolving obviousness standard in pharmaceutical patent law.
Join Jason A. Lief, Partner, at Windels Marx Lane & Mittendorf, LLP and Max H. Yusem, Of Counsel, Litigation Department, at Paul Hastings, LLP as they provide expert analysis and practical guidance based on recent court decisions, FDA actions, and real-world case studies. From Purdue v. Accord to Teva v. Amneal, this program will help attorneys and regulatory professionals navigate the shifting landscape of ANDA litigation, Orange Book strategy, and exclusivity protections.
Key Topics:
Key legal standards for obviousness in pharmaceutical patent cases, including KSR and Purdue v. Accord
Strategies for Orange Book listings, delisting requests, and managing Paragraph III/IV certifications
Recent FDA guidance and Federal Circuit rulings impacting Hatch-Waxman litigation
About The Knowledge Group
Founded in November 2006, The Knowledge Group has been at the forefront of providing quality continuing education programs for lawyers, accountants, financial executives, risk and compliance specialists, human resources professionals, technology officers, and business consultants in a wide range of industries.
The Knowledge Group strives to be the best-in-class provider of continuing education by bringing forth relevant content you can’t get anywhere else.
Contact:
Therese Lumbao
Director, Account Management & Member Services
The Knowledge Group, LLC
info ( @ ) theknowledgegroup dot org
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam